LONDON, Jan. 26 (UPI) -- GlaxoSmithKline says it received a positive opinion in Europe for albiglutide, under the brand name Eperzan, for treatment of type 2 diabetes. GSK officials said the Committee for Medicinal Products for Human Use ...
Tags: Albiglutide, Glaxosmithkline, FDA
Better diabetes treatment has slashed rates of complications such as heart attacks, strokes and amputations in older adults, a new study shows. "All the event rates, if you look at them, everything is a lot better than it was in the ...
Tags: diabetes treatment, hypoglycemia, low blood sugar, diabetes
Polymer Technology Systems, Inc. (PTS), the U.S.-based manufacturer of the CardioChek family of point-of-care diagnostic products, announced today that it has acquired the A1CNow® family of products from Bayer Diabetes Care. The ...
Sanofi has released results of a 24-week Phase IIIb clinical trial showing that Lyxumia (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered to patients either before breakfast or the ...
Tags: Diabetes Drug, Medicine
Nuvilex has announced last week that it has acquired the exclusive worldwide rights to a cellulose-based live-cell encapsulation technology for the development of treatments for diabetes. In order to pull off the acquisition, Nuvilex had ...
Tags: Nuvilex, Diabetes Technology
British drug-maker GlaxoSmithKline (GSK) has reached settlement with the attorneys general of eight US states over misleading marketing of the diabetes treatment drug, Avandia, and even agreed to pay $229m to settle the lawsuits. Without ...
Tags: Avandia Lawsuits, Medicine
Mendor, a Finland-based diabetes technology firm, has received CE Mark clearance for its diabetes management cloud-based platform, Mendor Balance. Delivering benefits to patients, health care professionals, payers and the pharma industry, ...
Mitsubishi Tanabe Pharma is seeking manufacturing and marketing approval of TA-7284 (generic name: canagliflozin) in Japan. The company filed a new drug application to the Ministry of Health, Labor and Welfare in Japan for TA-7284 to ...
Tags: Mitsubishi, canagliflozin
Swiss-based medical devices firm Debiotech has entered into an exclusive partnership agreement with Valtronic for the manufacturing of the electronic Controller unit for Debiotech's insulin product JewelPUMP. The insulin pump, which is ...
Tags: insulin pump, medical devices, JewelPUMP
US-based Tandem Diabetes Care has purchased Smiths Medical's over 23 US patents and patent applications relating to the treatment of diabetes. The acquisition of patents and patent applications will complement Tandem's intellectual ...
Tags: diabetes treatment, Diabetes
The European Commission has issued clearance to market Novo Nordisk's diabetes therapies, Tresiba and Ryzodeg, across 27 European Union (EU) states. Novo Nordisk anticipates launching Tresiba, brand name of insulin degludec, in the UK and ...
Tags: Ryzodeg diabetes drugs, injection doses, diabetes therapies